{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-026234","form_type":"8-K","ticker":"SDEV","cik":"0001389545","company_name":"Stablecoin Development Corp","filed_at":"2021-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.333343+00:00","generated_at":"2026-06-28T09:03:09.050027+00:00","sec_items":["2.01","5.02","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NovaBay closes $12M acquisition of DERMAdoctor; founders appointed to leadership, board seat planned","bullets":["Acquisition of DERMAdoctor closed Nov 5, 2021 for $12M cash plus up to $3M earn-out over 2 years.","Co-founders Dr. Audrey Kunin (Chief Product Officer) and Dr. Jeff Kunin (President) appointed; base salaries $200K and $150K respectively.","Dr. Audrey Kunin to be appointed to NovaBay Board as Class I director no later than 2022 annual meeting.","Funded by working capital and private placement of Series B preferred & warrants raising $15M gross proceeds.","Q3 2021 earnings call scheduled for Nov 11 at 4:30 PM ET; will discuss combined company plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-026234","json":"https://secwatch.observer/filing/0001437749-21-026234.json","markdown":"https://secwatch.observer/filing/0001437749-21-026234.md","text":"https://secwatch.observer/filing/0001437749-21-026234.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1389545/000143774921026234/0001437749-21-026234-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1389545/000143774921026234/nby20211110_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T09:03:09.050027+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81d8c2ebd8","claim":"Dr. Audrey Kunin was appointed as Chief Product Officer at Stablecoin Development Corp.","evidence_excerpt":"Drs. Audrey Kunin and Jeff Kunin were appointed to serve as DERMAdoctor’s Chief Product Officer and President, respectively.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774921026234/0001437749-21-026234-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Product Officer"}],"fact_type":"executive_change"},{"claim_id":"f3bf9709c3","claim":"Dr. Jeff Kunin was appointed as President at Stablecoin Development Corp.","evidence_excerpt":"Drs. Audrey Kunin and Jeff Kunin were appointed to serve as DERMAdoctor’s Chief Product Officer and President, respectively.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774921026234/0001437749-21-026234-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}